-
qualityindicators.ahrq.gov/News/PSI90_Factsheet_FAQ_V1.pdf
August 31, 2016 - 12 events in this
population may be less preventable due to safety concerns with
pharmacological prophylaxis
-
qualityindicators.ahrq.gov/News/PSI90_Factsheet_FAQ.pdf
August 31, 2016 - 12 events in this
population may be less preventable due to safety concerns with
pharmacological prophylaxis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - of
spine; Fever;
Juvenile rheumatoid
arthritis;
Myocardial infarction;
Myocardial infarction;
Prophylaxis … flurbiprofen Elimination half-life
range- 3.36 to 11.55
hrs
Constricted pupil,
intraoperative
prophylaxis … agents
Rofecoxib=35.3%
Celecoxib=21.9%
p<0.0001
(a)
Cardiovascular
TE
(b)
Cerebrovascular … agents
(a) 1.04 (0.50, 2.17)
(b) 1.43 (0.86, 2.38)
(c) 0.36 (0.01, 1.34)
n/a (a) increased risk … associated with age,
sex, cc aspirin use, cc
antiplatelet/anticoagulant
agents
(b) increased risk
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - of
spine; Fever;
Juvenile rheumatoid
arthritis;
Myocardial infarction;
Myocardial infarction;
Prophylaxis … flurbiprofen Elimination half-life
range- 3.36 to 11.55
hrs
Constricted pupil,
intraoperative
prophylaxis … agents
Rofecoxib=35.3%
Celecoxib=21.9%
p<0.0001
(a)
Cardiovascular
TE
(b)
Cerebrovascular … agents
(a) 1.04 (0.50, 2.17)
(b) 1.43 (0.86, 2.38)
(c) 0.36 (0.01, 1.34)
n/a (a) increased risk … associated with age,
sex, cc aspirin use, cc
antiplatelet/anticoagulant
agents
(b) increased risk
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Kizer1.pdf
April 01, 2004 - procedure for his or
her risk of surgical site infection (SSI), and implement appropriate antibiotic prophylaxis … all “high alert” drugs (e.g., intravenous adrenergic agonists and antagonists,
chemotherapy agents, anticoagulants
-
www.qualitymeasures.ahrq.gov/research/findings/final-reports/ssi/ssiapm.html
April 01, 2018 -
1
intra-op drugs on paper anesthesia record
D
Electronic
1
Peri-Op VTE Prophylaxis
-
ce.effectivehealthcare.ahrq.gov/research/findings/final-reports/ssi/ssiapm.html
April 01, 2018 -
1
intra-op drugs on paper anesthesia record
D
Electronic
1
Peri-Op VTE Prophylaxis
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/hai/clabsi-tools/vascular-access-device-policy.pdf
March 01, 2008 - INR or a PTT ratio > 1.3, platelets < 50K) or if patient
is on therapeutic dosing of thrombolytics/anticoagulants … The nurse may remove central VAD for patients on anticoagulants for Venous Thromboembolism
(VTE) Prophylaxis … The following are considered prophylactic dosing for VTE:
Drug Usual prophylaxis dose
Heparin 5000
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Ehringer_17.pdf
February 08, 2008 - include information beyond what the physician might initially consider, such as venous
thromboembolism prophylaxis … Venous thromboembolism
prophylaxis
Sequential compression devices for bilateral lower extremities … Adding DVT prophylaxis, vaccination status, smoking counseling, patient education, etc
Adding safety
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol2/Advances-Ehringer_17.pdf
February 08, 2008 - include information beyond what the physician might initially consider, such as venous
thromboembolism prophylaxis … Venous thromboembolism
prophylaxis
Sequential compression devices for bilateral lower extremities … Adding DVT prophylaxis, vaccination status, smoking counseling, patient education, etc
Adding safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemophilia-dental-rapid-response.pdf
July 01, 2024 - In dental procedures that required local anesthesia, it was
recommended that children on routine prophylaxis … for factor therapy differed for adults versus
children—it was recommended that children on routine prophylaxis … PubMed search history on November 30, 2023
Search
Number
Query Results
1 "Dental Prophylaxis"[ … 3] OR "dental extraction"[Title/Abstract:~3] OR "dental
extractions"[Title/Abstract:~3] OR "dental prophylaxis … Spanish consensus
guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hemophilia-dental-rapid-response.pdf
July 01, 2024 - In dental procedures that required local anesthesia, it was
recommended that children on routine prophylaxis … for factor therapy differed for adults versus
children—it was recommended that children on routine prophylaxis … PubMed search history on November 30, 2023
Search
Number
Query Results
1 "Dental Prophylaxis"[ … 3] OR "dental extraction"[Title/Abstract:~3] OR "dental
extractions"[Title/Abstract:~3] OR "dental prophylaxis … Spanish consensus
guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia
-
digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-slides-081811.pdf
August 18, 2011 - 100 120
Drug interactions
Inadequate monitoring
Failure to act on monitoring
Known allergy
No prophylaxis
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017010-bailey-final-report-2011.pdf
January 01, 2011 - previous work we
have shown that ambulatory ADEs related to high-alert medications – particularly anticoagulants … started during
hospitalization may be continued without adequate outpatient monitoring (e.g., oral
anticoagulants … definition: “an effect which is
noxious and unintended, and which occurs at doses used in man for prophylaxis … hazardous
medications that are used heavily in adults, but much less frequently in children – such as
anticoagulants
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Pediatric cardiac surgery
A total of 40 patients received rFVIIa prophylaxis in
one poor quality RCT
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Pediatric cardiac surgery
A total of 40 patients received rFVIIa prophylaxis in
one poor quality RCT
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
January 01, 2002 - At that time, the Task
Force found insufficient evidence to recommend for
or against routine aspirin prophylaxis … Concomitant use of other nonsteroidal
anti-inflammatory agents or anticoagulants
further increased risk … Aspirin for the Primary Prevention of Cardiovascular Events
24
Adults without
known CVD Aspirin prophylaxis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
April 01, 2012 - concomitant
prescription drugs from, on average,
5.9 different drug classes for primary and
secondary prophylaxis … : 40-55 years
Mixed gender
Unclear CHD risk
6-25 weeks treatment
INR Vitamin K (150 μg /day) + Anticoagulants … combination
with antiplatelet agents (acetylsalicylic acid,65,66
clopidogrel,67 or ticlopidine68), an anticoagulant … Overall evidence indicates that supplementation with
vitamin K may improve the stability of anticoagulant … or
withdrawal due to adverse events.41 This study recruited
70 participants with indications for anticoagulant
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
April 01, 2012 - concomitant
prescription drugs from, on average,
5.9 different drug classes for primary and
secondary prophylaxis … : 40-55 years
Mixed gender
Unclear CHD risk
6-25 weeks treatment
INR Vitamin K (150 μg /day) + Anticoagulants … combination
with antiplatelet agents (acetylsalicylic acid,65,66
clopidogrel,67 or ticlopidine68), an anticoagulant … Overall evidence indicates that supplementation with
vitamin K may improve the stability of anticoagulant … or
withdrawal due to adverse events.41 This study recruited
70 participants with indications for anticoagulant
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs026732-usher-final-report-2023.pdf
January 01, 2023 - ; 95% CI,
0.66-0.99) and the use of COVID-19–specific therapeutics including deep vein thrombosis
prophylaxis